WAY

Waystar Holding Corp. 10-Q Summary: Q3 2024

Business Context and Reporting Period

This report covers the quarterly period ended September 30, 2024. Waystar Holding Corp. is a provider of mission-critical cloud technology for healthcare organizations, focusing on payment processing, claim accuracy, and patient engagement. The company completed its Initial Public Offering (IPO) in June 2024, raising approximately $1.02 billion in net proceeds (including overallotment), which was primarily used to repay significant portions of its First Lien Credit Facility.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Q3 2024 revenue increased 21.7% year-over-year. This was driven by a 27.8% increase in volume-based revenue and a 15.9% increase in subscription revenue. Management attributes approximately $12 million of Q3 revenue growth to accelerated client adoption following a cybersecurity incident at a competitor in February 2024.
• Profitability: The company reported a net income of $5.4 million in Q3 2024, a reversal from a net loss of $15.5 million in Q3 2023. This improvement was primarily due to a significant reduction in interest expense following debt paydowns.
• Interest Expense: Interest expense decreased by 65.0% in Q3 2024 compared to the prior year, dropping from $50.8 million to $17.8 million, driven by the repayment of over $1 billion in debt principal using IPO proceeds.
• Operating Expenses: General and Administrative (G&A) expenses increased 30.7% in Q3, largely due to a $3.6 million increase in stock-based compensation related to the IPO and new equity grants. Depreciation and amortization increased 37.8% due to $15.8 million in accelerated depreciation from an office relocation.

Guidance, Outlook, and Risks

• Outlook: Management expects to incur approximately $17.9 million annually in stock-based compensation related to IPO grants. The company anticipates continued growth driven by existing client expansion and the adoption of patient payment solutions.
• Capital Structure: Following the IPO and subsequent debt repayments, the company's total outstanding debt was reduced to approximately $1.25 billion. The First Lien Credit Facility bears interest at SOFR + 2.75%.
• Risks: Key risks include the highly competitive healthcare technology landscape, reliance on third-party vendors, regulatory changes in healthcare, and the potential for cybersecurity incidents. The company also faces risks related to its status as an "emerging growth company" and the ability to retain key personnel.
• Unusual Items: The period included significant one-time costs related to the IPO, debt extinguishment losses (totaling approximately $20.3 million for the nine months ended Sept 30, 2024), and accelerated depreciation due to office relocation.

Investor Verification Checklist

• Debt Covenants: Verify compliance with the First Lien Credit Facility covenants, particularly regarding leverage ratios and interest coverage, given the recent refinancing and paydowns.
• Stock-Based Compensation: Review the sustainability of operating margins excluding the one-time $33.1 million stock-based compensation charge recognized in 2024 due to the IPO making performance options probable.
• Competitor Impact: Assess the durability of the revenue growth attributed to the competitor's cybersecurity incident; determine if this represents a permanent shift in market share or a temporary spike.
• Office Relocation Costs: Confirm the total impact of the Louisville office relocation on future depreciation schedules and operating lease costs.
• Net Revenue Retention: Validate the 109.4% Net Revenue Retention Rate to ensure it reflects organic growth and not solely pricing changes or one-time implementation fees.